WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Barcelona's De Jong out for season, ready for EurosChinese vice premier urges intensified emergency rescue, flood response workBoosted by sciUN expert warns of decimated right to health in GazaSearch continues for 6 missing after Taiwan's 7.3I'm an American living in the UK... here is the TRUTH about who has the better foodAuthorities name driver fatally shot by deputies in Memphis after he sped toward themChina's top legislator holds talks with Kazakhstan officialChina's industrial profits up 4.3 pct in Q1Suzhou museum unveils rare masterpiece